ON DEMAND WEBINAR
Duration: 1 hour​

The commercial success of GLP-1-based drugs has reignited interest in peptide therapeutics, driving increased investment and a surge in peptide drug candidates. But as momentum builds, so do the stakes, and the development path is filled with challenges: peptides straddle the line between small and large molecules, demanding specialized techniques for stability, aggregation, and impurity analysis. As delivery systems evolve, particularly with the rise of autoinjectors, factors like viscosity, container closure integrity, and excipient interference add layers of complexity. 

Join experts from Solvias as they share insights on mastering these challenges. Learn how to safeguard product quality, meet global regulatory expectations, and streamline development by integrating analytics early in your strategy. Whether you’re navigating early-stage development or scaling up for commercial release, this webinar offers practical strategies for success across the peptide product lifecycle.

SPEAKERS

Jürgen Rotzler, PhD
Small Molecule & Product and Manufacturing Services Business Unit Head
Solvias
 

Achim Link, PhD
Field Development Services Manager
Solvias